Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation (Q31036740)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

author name string

Hideharu Abe

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Takeshi Matsubara

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Noriyuki Iehara

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Kojiro Nagai

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Toshikazu Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Hidenori Arai

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Toru Kita

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Toshio Doi

8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

19 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

14201-14206

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

The mesangial cell: a tissue culture view

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Cloning of the large subunit of activator 1 (replication factor C) reveals homology with bacterial DNA ligases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Rb Interacts with Histone Deacetylase to Repress Transcription

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

T-box gene tbx5 is essential for formation of the pectoral limb bud.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Transcriptional control by the TGF-beta/Smad signaling system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Characterization of a bone morphogenetic protein-responsive Smad-binding element

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

TGF-β signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Smad3 mutant mice develop metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Arteriovenous malformations in mice lacking activin receptor-like kinase-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M310427200

21 January 2018

Identifiers

10.1074/JBC.M310427200

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31036740&oldid=1978669968"